Virtual event on
The event will feature a presentation from key opinion leader
Topics of discussion will also include the patient and caregiver perspective on the burden of disease, preclinical pharmacology and toxicology data for TSHA-118, and the clinical development strategy for the TSHA-118 program. A question and answer session will follow each formal presentation.
The event will feature presentations from:
Sharon King, President of Taylor’s Tale, who will discuss the burden of disease and provide a patient and caregiver perspective
Steven Gray, Ph.D., Associate Professor in the Department of Pediatricsat UT Southwestern and Chief Scientific Advisor at Taysha, who will review the preclinical and pharmacology data for TSHA-118 for the treatment of CLN1 disease
Suyash Prasad, MBBS, M.Sc., MRCP, MRCPCH, FFPM, CMO and Head of R&D of Taysha, who will discuss the clinical development strategy for TSHA-118
Registration for this event is available through LifeSci Events. A live video webcast will be available in the “Events & Media” section of the Taysha corporate website. An archived version of the event will be available on the website for 60 days.
SVP, Corporate Communications and Investor Relations